Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223300 · ClinicalTrials.gov registry record
Osteoporosis Research Registry
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 12
- Enrollment target
NCT01223300: Completed study, sponsored by Northwestern University.
NCT01223300 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01223300 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The aim of this research registry is to collect information on individuals with osteoporosis, those with risk factors for osteoporosis, and comparative healthy controls. Bone mineral density measurements will be done on these individuals to determine bone health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-11 |
| Est. Completion | 2016-12 |
What the finished NCT01223300 record still lists
NCT01223300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01223300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01223300 about?
NCT01223300 is a clinical study titled "Osteoporosis Research Registry". The aim of this research registry is to collect information on individuals with osteoporosis, those with risk factors for osteoporosis, and comparative healthy controls. Bone mineral density measurements will be done on these individuals to determine bone health.
What is the current status of trial NCT01223300?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2008-11. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01223300?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia